Sarah is a Specialist in the area of Medicines and Advanced Therapies, also supporting medical biotechnology and bioprocessing. She is one of the KTN representatives on the Medicines Manufacturing Industry Partnership, and also works on the Advanced Therapies Manufacturing Taskforce with industry and government.
Sarah joined KTN in 2010 as Technical Manager from the UK BioIndustry Association. While at the BIA, Sarah worked in public affairs and membership roles nationally, on BIA’s Science and Clinical Development agenda and was appointed Acting Director at BIA Scotland as well as helping to set up the BIA’s RegenMed Industry Group and Committee.
She has a PhD in Developmental Biology with several years of postdoctoral experience.